Home » Topics » Regulatory » Patents

Patents
RSS

Recent GSK patent describes new analgesic agents

Oct. 6, 2008

Novel treatments for endocrine-associated disorders imparted in recent patents

Oct. 6, 2008

New treatment option for Wilson's disease disclosed in recent SSV patent

Oct. 6, 2008

Recent Rice University patent describes new antiinflammatory agents

Oct. 3, 2008

Novel agents for rheumatoid arthritis disclosed in recent Janssen and Kyorin patents

Oct. 3, 2008

New anticancer agents imparted in recent patents

Oct. 3, 2008

New agents for treating neurological disorders disclosed in recent patent literature

Oct. 2, 2008

Recent Tibotec patents report novel therapeutic agents for HCV infection

Oct. 2, 2008

Novel antiinfective agents disclosed in recent MicuRx and GSK patents

Oct. 2, 2008

Recent Kowa patent describes novel STAT-6 activation inhibitors

Oct. 1, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....